Factors affecting long-term outcome after allogeneic haematopoietic stem cell transplantation for acute myelogenous leukaemia: a retrospective study of 172 adult patients reported to the Austrian Stem Cell Transplantation Registry.
about
Intensive care outcomes in adult hematopoietic stem cell transplantation patientsOutcomes from unrelated donor hematopoietic stem cell transplantationExtramedullary relapse of acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation: incidence, risk factors and outcomesThe need for endodontic treatment and systemic characteristics of hematopoietic stem cell transplantation patients.A Chemotherapy-Only Regimen of Busulfan, Melphalan, and Fludarabine, and Rabbit Antithymocyte Globulin Followed by Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplantations for the Treatment of Myeloid Malignancies.Intensive consolidation with G-CSF support: Tolerability, safety, reduced hospitalization, and efficacy in acute myeloid leukemia patients ≥60 years.Survival after reduced-intensity conditioning is not inferior to standard high-dose conditioning before allogeneic haematopoietic cell transplantation in acute leukaemias.Reevaluation of the National Institutes of Health criteria for classification and scoring of chronic GVHD.Increased activity and improved outcome in unrelated donor haemopoietic cell transplants for acute myeloid leukaemia in Australia, 1992-2005.Improved outcome in relapsed and refractory myeloid malignancies for unrelated vs related donor allogeneic peripheral blood-derived hematopoietic cell transplantation.Myeloablative conditioning is well tolerated by older patients receiving T-cell-depleted grafts.Impact of pre-transplant marrow blasts on survival of allogeneic stem cell transplantation in adult acute myeloid leukemia.Impact of disease burden at time of allogeneic stem cell transplantation in adults with acute myeloid leukemia and myelodysplastic syndromes
P2860
Q26767031-1E8A68B0-7630-4D30-998A-A98B6CCCC9B7Q27027854-976CC6E0-3E46-46E2-A754-B1A9DD70C874Q36579060-33102BE2-4490-4A5F-8461-C30434530F8FQ38692751-0E23BAA8-C00A-47F5-823D-09CF1FFA82F3Q40121414-738EB1E3-5EEF-41A2-93EC-DEA9CB7283C3Q40138696-4A4E19B7-D76F-4758-8820-75670431F1EFQ44462441-F74F1E76-170B-4D5E-ABB1-82FF348AA630Q44772306-19B8ECB6-C308-4595-B194-9CE0D42F9081Q45808982-7CA99B6A-8798-43F4-A993-36CA12CF5B02Q46029759-9D286071-A98A-4B0E-B90A-3709773568B6Q46661656-9954E41E-ABC1-4996-9303-A40EB71D9852Q53114550-D503B7E2-DA11-4105-9EA6-CBCBD0E886CAQ59315421-6A0C3ACA-5818-47D1-A21B-0C8338B6F141
P2860
Factors affecting long-term outcome after allogeneic haematopoietic stem cell transplantation for acute myelogenous leukaemia: a retrospective study of 172 adult patients reported to the Austrian Stem Cell Transplantation Registry.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Factors affecting long-term ou ...... Cell Transplantation Registry.
@en
Factors affecting long-term ou ...... Cell Transplantation Registry.
@nl
type
label
Factors affecting long-term ou ...... Cell Transplantation Registry.
@en
Factors affecting long-term ou ...... Cell Transplantation Registry.
@nl
prefLabel
Factors affecting long-term ou ...... Cell Transplantation Registry.
@en
Factors affecting long-term ou ...... Cell Transplantation Registry.
@nl
P2093
P2860
P1476
Factors affecting long-term ou ...... Cell Transplantation Registry.
@en
P2093
Agathe Rosenmayr
Beate Gritsch
David Nachbaur
Dieter Lutz
Dietger Niederwieser
Hildegard T Greinix
Klaus Lechner
Margit Eibl
Otto Krieger
Paul Knöbl
P2860
P304
P356
10.1046/J.1365-2141.2002.03532.X
P407
P577
2002-06-01T00:00:00Z